Vivienne Ming: Tracking My Son's Diabetes

August 10, 2018

Vivienne Ming is an accomplished neuroscientist and an entrepreneur, however this project is not about her kick-ass professional work, instead, it’s deeply personal about how she manages her son’s diabetes. Vivienne presented her project, Tracking My Son’s Diabetes at the 2013 QS Global Conference.
When Vivienne’s not conducting research or working on new ideas she’s busy taking care of her son, Felix. Two years prior Felix was diagnosed with Type 1 Diabetes. Vivienne and her partner tackled his diagnosis head on and started tracking everything they could. In this talk, Vivienne learns through tracking her son’s heart rate and blood sugar constantly that stress is a factor of his blood sugar level peaks. She explains what they’re learning together about tracking her son’s diabetes.

Vivienne Ming presents her talk at the 2013 QS Global Conference

Vivienne Ming presents her talk at the 2013 QS Global Conference

We hope you can join us to share your learnings from a project, or simply be inspired at this year’s Quantified Self 2018 Conference in Portland on September 22-23. Register here.

Related Posts

CGM Show&Tell June 13 2023

Gary Wolf

June 13, 2023

Vivienne Ming is an accomplished neuroscientist and an entrepreneur, however this project is not about her kick-ass professional work, instead, it’s deeply personal about how she manages her son’s diabetes. Vivienne presented her project, Tracking My Son’s Diabetes at the 2013 QS Global Conference. When Vivienne’s not conducting research or working on new ideas she’s...

New Show&Tell Event: Tracking Blood Glucose

Gary Wolf

May 31, 2023

Please join us for an hour of short "QS Show&Tell" talks about diet and metabolic discoveries using personal science. This session will focus on minimally invasive blood glucose monitor and meal and activity tracking with Nutrisense.

Astronauts

Gary Wolf

February 23, 2023

We The Scientists, a new book by Amy Dockser Marcus, tells the story of a group of families who force research attention on a rare disease